Litcius/Paper detail

Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression

Hildegund C.J. Ertl

2023Drugs35 citationsDOI

Topics & Concepts

MedicineAntibodyGenetic enhancementTransduction (biophysics)Adverse effectViral vectorVector (molecular biology)Neutralizing antibodyImmunologyImmunosuppressionVirologyImmune systemVirusPharmacologyBiologyGeneBiochemistryRecombinant DNAVirus-based gene therapy researchCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in Insects
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression | Litcius